CA2143094A1 - Method and apparatus for controlled individualized medication - Google Patents
Method and apparatus for controlled individualized medicationInfo
- Publication number
- CA2143094A1 CA2143094A1 CA002143094A CA2143094A CA2143094A1 CA 2143094 A1 CA2143094 A1 CA 2143094A1 CA 002143094 A CA002143094 A CA 002143094A CA 2143094 A CA2143094 A CA 2143094A CA 2143094 A1 CA2143094 A1 CA 2143094A1
- Authority
- CA
- Canada
- Prior art keywords
- medication
- rules
- medicine
- patient
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0481—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers working on a schedule basis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0418—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with electronic history memory
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0454—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers for dispensing of multiple drugs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/30—Compliance analysis for taking medication
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/923—Computer assisted medical diagnostics by comparison of patient data to other data
- Y10S128/924—Computer assisted medical diagnostics by comparison of patient data to other data using artificial intelligence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S706/00—Data processing: artificial intelligence
- Y10S706/902—Application using ai with detail of the ai system
- Y10S706/924—Medical
Abstract
A method and a device for giving patients individualised, situation-dependent medication advice are disclosed. Preferably, the invention is implemented in portable computers. The method is founded on knowledge-based computer technology and com-prises a reminder function (1), a recording and storage function (2, 3), as well as a function for inductive data analysis (4) and rule generation. When the knowledge-based system (6) finds that a medicine should be taken, the computer emits a signal provid-ing information on the type of medicine and the dose. The patient records the intake of medicine as well as his current state of health. This information is stored in a database together with the point of time. Inductive data analysis is used to spot the rela-tionship between various events and symptoms as well as establish medication rules. These rules are refined upon as new infor-mation is recorded in the database, and are automatically adapted to changes in the patient's state of health.
Description
W094/06088 214 3 0 9 ~ PCT/SE93/00708 Method and apparatus for controlled individualized medication.
This invention relates to a method for controlled individualised medication.
Many chronic diseases in man reguire the ~m; ni stra-tion of various subst~nr~-c in order to counteract the dis-ease and/or to keep down its symptoms. Medication often includes several different pharmaceutical preparations, each having its specific properties, duration of action, and so forth. Dosage and time intervals between ~mi n; -strations depend on the status of the disease, patient-specific factors, such as inheritance, age, weight, gene-ral state of health as well as diet and physical activi-ties. As a result, medication is a fairly complicated task to perform. In practice, this will manifest itself as variations in the patient's state of health. In the case of some diseases, such as Parkinson's disease, the symptoms may in a single day vary from making the patient incapacitated for work (rigidity, tremor, etc.) to leaving the patient almost untroubled.
There are several different methods used for provid-ing recomm~n~tions as to the dosage and the time inter-vals between administrations. These recomm-endations are often founded on the adjustment of an initial concept based on pharmacokinetic information on the various pre-parations. The adjustments are made on the basis of recor-dations of the patient's condition on various occasions.
This information is interpreted by specialists, and used for adjusting the dosage and the time intervals.
However, the methods currently used do not yield desirable results, the reason being that the pharmacokine-tic effects of the preparations are not absolutely clear.
The way the preparations move through the body is affected by interactions with other preparations, enzymes and so forth, during the absorption and the distribution phase as well as during the metabolism and the secretion phase.
Thus, the actual concentration of a preparation in the W O 94/06088 214 3 ~ 9 ~ PC~r/SE93/00708 --biophase, the duration of action and the effect cannot be predicted statistically using monotonic models. Another reason is that the evaluation of the patient's data is a complex operation since it involves many dependent vari-ables and since it further is difficult to lay down analy-tical models.
It is likely that the stat~ of health of certain groups of patients can be drastically improved by optimum, individualised and situation-dependent medication. This would result in ~nh~nc~A quality of life, as well as fewer sickness pensioners.
GB 2,218,831 teaches an apparatus for helping people suffering from chronic diseases, such as diabetes, to determine medication doses and keep a suitable diet, thereby to improve their state of health. This apparatus has a key pad for entering data on the blood glucose levels as well as the physical activity of the patient, a memory where e.g. data on the prescribed dosage are stored, a program for computing suitable doses of insulin on the basis of inputted data as well as data stored in the memory, and a display for showing the doses of insulin computed.
Similar apparatus are described in US Patent 5,019,974 and EP Patent Application 0 128 054.
These prior-art apparatus are all based on there being a known relationship between a condition of the patient, such as the blood glucose level, and the well-being of the patient, and on the medication having a known effect on the patient. Thus, one may establish fixed medi-cation rules valid for comparatively long periods of time.
However, in the case of other chronical diseases, such as Parkinson's disease, epilepsy and abnormal blood pressures, there does not exist any single actual value or condition of the patient that can be measured and corre-lated with the well-being of the patient. For these dis-eases, medication generally includes several medicines, whose precise interactions and effects on the patient are ~ W O 94/06088 21 ~ 3 0 9 ~ Pl~r/SE93/00708 not fully known. In addition, the health condition of the patient is affected by a plurality of external factors.
Thus, it is impossible to establish fixed medication rules valid for long periods of time, and the prior-art appara-tus therefore cannot be used for controlled individualisedmedication in the treatment of more complicated diseases.
The ob~ect of the present invention is to provide a method and a device for controlled, individualised medi-cation in the treatment of complicated ~i~e~ces whose mechanisms are not fully known, thereby to improve the patient's state of health.
This object is attained by a method and a device hav-ing the distinctive features recited in appended claims 1 and 9, respectively. Other features of the invention are stated in the appended subclaims.
The invention has the great advantage of automatical-ly drawing conclusions from the inputted data as to what activities, what external factors and what medication will result in a satisfactory state of health for the patient.
On the basis of these conclusions, rules are established regarding when and in what doses the different medicines are to be taken. The thus-established rules are not fixed, but are continuously refined upon with the aid of data recorded by the patient. Thus, the invention gradually "learns" what is needed for the well-being of the patient.
Further, the rules are automatically adapted to changes in the patient without the device having to be reprogrammed.
The invention will be described in more detail below with reference to the ~c~omranying ~rawing, which ~h~
tically illustrates the structure of a device in accor-dance with the invention.
The aim of the invention is to give the patients con-trolled, individualised and situation-dependent medication advice, thereby to enhAn~e the patient's sense of well-being to an optimum extent. The inventive method is adap-tive, i.e the basic rules for the advice are altered if the relevant factors affecting the patient are changed.
W O 94/06088 214 3 0 9 4 PC~r/SE93/00708 ~
Conveniently, the invention is implemented in portable "wallet-size" computers.
As appears from the drawing, the method is founded on a knowledge-based computer system or expert system 6 having a r~mi n~er function 1, a recording and storage function 2, 3, as well as a function 4 for inductive rule generation.
When the system is operating, the reminder function 1 is normally activated. The computer emits a signal when a pharmaceutical preparation is to be taken (or some other activity is to be performed), and advises on the type of preparation to be taken as well as the dosage. In the recording function 2 of the system, the patient confirms that the medicine has been taken, and then indicates his current state of health by respon~ing to guestions put to him by the computer. In addition, the patient separately records other relevant events, such as awakP.ni ng, intake of food, exercise and stress, when these occur, and also indicates his current state of health.
These data are stored in a database 3 together with the point of time at issue. Optionally, some information may be automatically retrieved by sensors.
The information, which constitutes a situation data-base 3, is used for determi ni ng relevant relations in time between various events and to generate examples distin-guishing the different symptoms that are to be controlled.
The examples consist of values for the attributes (affect-ing factors) that are relevant, as well as the associated symptom value (conclusion). The attributes used for each preparation are, among others, "latest dosage", "time from intake", and "rem~in;ng duration of action".
Collections of examples are automatically created every day for each group of symptoms. These collections are accumulated in a "rolling" database, preferably including the values from the last 20 days. The examples are then used in each group of symptoms for spotting, with the aid of prior-art inductive data analysis 4, the rela-2143~94 tionships that exist, and drafting rules for predictingthe symptoms.
Inductive data analysis and rule generation are described in, inter alia, the following publications:
Quinlan, JR (1979), Discovering Rules by Induction from Large Collections of Examples, Introductory ReA~ ings in Expert Systems (D. Michie), pp 33-46, London; Gordon and Breach 1979. Quinlan, JR (1983), Learning from Noisy Data, ProcPe~;ngs of the International ~Ach;n~ Learning Work-shop, University of Illinois, pp 58-64, 1986.
The prediction rules are generated in the form of decision trees and/or so-called conditional rules of the type:
IF X1<0.12 AND Z3="protein B" AND Z1>0.34 AND Z2=2 THEN
RIGIDITY = "excessive agility".
The rules are validated by being tested at 5 against borderline cases drawn up on long-term experience. Approv-ed rules are transferred to the knowledge base in an expert system 6 in known ~~nne~. The expert system may be a conventional rule-based system or be based on fuzzy logic. Then, the expert system is able to predict the state of health of the patient by part predictions of the various symptoms in a specific situation.
When in use, the expert system is automatically called at 8 at regular time intervals, preferably every fifth minute. When called, the system is consulted with respect to the current values from the situation database.
In consultation, time data are displaced forwards, pre-ferably by a time factor corresponding to the time elaps-ing from the intake of a preparation to the attainment of its biophase. This makes it possible for the system to signal before any undesirable effects appear (early warn-ing system). The consultation is performed in known manner via "backward chaining", i.e. starting from a desirable W O 94/06088 PC~r/SE93/00708 ~
21~3~9 4 -conclusion (state of health). Desirable conclusions can be predetermined for every group of symptoms.
The expert system operates in real time and can, in each specific situation, find in good time the prerequi-sites and conditions that have to be met to achieve thedesired state of health. If this state cannot be achieved in a specific situation (e.g. because the patient has forgotten to act on previous advice), the system looks for the prerequisites for att~;n;ng the "second-best" state of health. Induction of rules and updating of the knowledge base are performed automatically by the system, conve-niently once every twenty-fourth hour. Because the system learns to detect patterns by induction of real situations, the system can provide individualised medication advice without having access to explicit causal connections and pharmacological data, the prerequisite being that the attributes used directly or indirectly represent patterns that can be classified. According to the invention, the patient records the point of time when he takes the various preparations, the dosage as well as his current state of health. These data are used for generating, by inductive data analysis, prediction rules that are used for providing advice on the point of time and the dosage.
For each preparation, one starts from a patient-spe-cific longest nom;n~l duration of action. In the examples,the remaining duration of action as well as the dosage of the latest and the latest-but-one intake are determined.
Also other relevant factors, such as the intake of food, state of stress and related time, are also included in the examples.
The prediction rules generated by prior-art inductive data analysis are called at predetermined intervals, and a time delay is then introduced, which preferably corre-sponds to the time elapsing, in the case of the different preparations, from the intake to the att~i~ent of the biophase. The prediction rules are called by backward chain, primarily in order to satisfy the current situation 21~30~
;-to attain the desired state of health. If any of the con-ditions that can be influenced is not satisfied, e.g. the dosage of a preparation, the system will rer~- ?nA that this be done.
5 A mode of operation of the invention, intPn~P~ for controlled, individualised adaptive medication in the treatment of Parkinson's disease, will be described below.
In Parkinson's disease, the body cannot produce sufficient amounts of a neurotransmitter in the brain called dopa-mine, which results in limitations of movement, muscular cramp and tremor. This state can be counteracted by the supply of various preparations, such as L-dopa, which are converted to dopamine or the substance bromokriptin. In order to master undesirable side-effects, such as effects on the blood pressure, these preparations generally have to be combined with other medicines. Thus, medication fre-quently involves at least three different preparations, each having a specific dosage and a specific time inter-val between administrations. Owing to the interactions taking place, the time intervals and the doses have to be adapted to one another. Also external factors, such as the intake of food, exercise and state of stress, affect the action of the preparations. As a result, patients that have been ill for a long time, and thus have had plenty of time to find which medication suits them best, are seldom perfectly untroubled for a whole day. Freguently, there are two or more periods during the day in which they expe-rience considerable discomfort in the form of tremor, rigidity and "dullness of mind". Too low a dosage typi-cally results in tremor, rigidity and muscular cramp. Dis-comfort caused by overdosage is not less common, manifest-ing itself in the form of uncontrolled excessive agility, among other things. The reminder function indicates when the preparations, such as Pravidel, Sinemet, Inderal, Madopark, and Eldepryl, are to be taken, and further pro-vides r~commendations as to the intake of liquid, food and rest.
21~3~
The recording function includes compulsory input of the state of health expressed as degrees of the attributes "Rigidity", "Agility", "Tremor" and "Dullness of Mind".
Recordation is also performed when other important events take place, such as "awakening", "falling asleep", "eat-ing" and "drinking". In recordation, the time is indicated in minutes from the awakenin~.
When generating examples, the times elapsing from the intake of the various preparations and events to the pre-sent time are determined. Two times are preferably deter-mined for each preparation, namely the time that has elapsed from the latest-but-one intake and the time that has elapsed from the latest intake.
A no~;n~l duration of action from the intake is used for the various preparations. When the individual duration of action is known, this is indicated.
At the end of each day, a collection of examples with attribute values determined as above is created.
The recorded state of health is indicated as conclusion for each example.
A collection of examples is thus made for each of the indicated states of health, i.e. one collection of exam-ples with the conclusion related to "Rigidity", one col-lection related to "Tremor", and one collection related to "Dullness of Mind". Then, rules are induced from the col-lections of examples, and the rules are validated by com-paring their threshold values with indicated ~X;~um and um limits as to dosage and time.
If a rule falls outside these limits, the indicated limit values are used.
Thereafter, the rules are transferred to the know-ledge base in a deductive expert system.
The generation of examples, the induction and the transfer to the database are initiated at the end of each day and are perfectly automatic.
-- 21~309~
W O 94/06088 ^ PC~r/SE93/00708 When using the system, the reminder function is acti-vated when the patient starts the computer upon awaken; ng.
The r~ nA~r function calls the expert ~ tem at intervals of preferably about 5 min, and the expert system is thus consulted with respect to the data recorded. In consultation, an advance tim~ corresponding to the average time elapsing from the intake of a preparation to its com-menced action, is added to the real time. Preferably, the advance time is 30 min. Consequently, the system will be able to issue reminders in good time.
This invention relates to a method for controlled individualised medication.
Many chronic diseases in man reguire the ~m; ni stra-tion of various subst~nr~-c in order to counteract the dis-ease and/or to keep down its symptoms. Medication often includes several different pharmaceutical preparations, each having its specific properties, duration of action, and so forth. Dosage and time intervals between ~mi n; -strations depend on the status of the disease, patient-specific factors, such as inheritance, age, weight, gene-ral state of health as well as diet and physical activi-ties. As a result, medication is a fairly complicated task to perform. In practice, this will manifest itself as variations in the patient's state of health. In the case of some diseases, such as Parkinson's disease, the symptoms may in a single day vary from making the patient incapacitated for work (rigidity, tremor, etc.) to leaving the patient almost untroubled.
There are several different methods used for provid-ing recomm~n~tions as to the dosage and the time inter-vals between administrations. These recomm-endations are often founded on the adjustment of an initial concept based on pharmacokinetic information on the various pre-parations. The adjustments are made on the basis of recor-dations of the patient's condition on various occasions.
This information is interpreted by specialists, and used for adjusting the dosage and the time intervals.
However, the methods currently used do not yield desirable results, the reason being that the pharmacokine-tic effects of the preparations are not absolutely clear.
The way the preparations move through the body is affected by interactions with other preparations, enzymes and so forth, during the absorption and the distribution phase as well as during the metabolism and the secretion phase.
Thus, the actual concentration of a preparation in the W O 94/06088 214 3 ~ 9 ~ PC~r/SE93/00708 --biophase, the duration of action and the effect cannot be predicted statistically using monotonic models. Another reason is that the evaluation of the patient's data is a complex operation since it involves many dependent vari-ables and since it further is difficult to lay down analy-tical models.
It is likely that the stat~ of health of certain groups of patients can be drastically improved by optimum, individualised and situation-dependent medication. This would result in ~nh~nc~A quality of life, as well as fewer sickness pensioners.
GB 2,218,831 teaches an apparatus for helping people suffering from chronic diseases, such as diabetes, to determine medication doses and keep a suitable diet, thereby to improve their state of health. This apparatus has a key pad for entering data on the blood glucose levels as well as the physical activity of the patient, a memory where e.g. data on the prescribed dosage are stored, a program for computing suitable doses of insulin on the basis of inputted data as well as data stored in the memory, and a display for showing the doses of insulin computed.
Similar apparatus are described in US Patent 5,019,974 and EP Patent Application 0 128 054.
These prior-art apparatus are all based on there being a known relationship between a condition of the patient, such as the blood glucose level, and the well-being of the patient, and on the medication having a known effect on the patient. Thus, one may establish fixed medi-cation rules valid for comparatively long periods of time.
However, in the case of other chronical diseases, such as Parkinson's disease, epilepsy and abnormal blood pressures, there does not exist any single actual value or condition of the patient that can be measured and corre-lated with the well-being of the patient. For these dis-eases, medication generally includes several medicines, whose precise interactions and effects on the patient are ~ W O 94/06088 21 ~ 3 0 9 ~ Pl~r/SE93/00708 not fully known. In addition, the health condition of the patient is affected by a plurality of external factors.
Thus, it is impossible to establish fixed medication rules valid for long periods of time, and the prior-art appara-tus therefore cannot be used for controlled individualisedmedication in the treatment of more complicated diseases.
The ob~ect of the present invention is to provide a method and a device for controlled, individualised medi-cation in the treatment of complicated ~i~e~ces whose mechanisms are not fully known, thereby to improve the patient's state of health.
This object is attained by a method and a device hav-ing the distinctive features recited in appended claims 1 and 9, respectively. Other features of the invention are stated in the appended subclaims.
The invention has the great advantage of automatical-ly drawing conclusions from the inputted data as to what activities, what external factors and what medication will result in a satisfactory state of health for the patient.
On the basis of these conclusions, rules are established regarding when and in what doses the different medicines are to be taken. The thus-established rules are not fixed, but are continuously refined upon with the aid of data recorded by the patient. Thus, the invention gradually "learns" what is needed for the well-being of the patient.
Further, the rules are automatically adapted to changes in the patient without the device having to be reprogrammed.
The invention will be described in more detail below with reference to the ~c~omranying ~rawing, which ~h~
tically illustrates the structure of a device in accor-dance with the invention.
The aim of the invention is to give the patients con-trolled, individualised and situation-dependent medication advice, thereby to enhAn~e the patient's sense of well-being to an optimum extent. The inventive method is adap-tive, i.e the basic rules for the advice are altered if the relevant factors affecting the patient are changed.
W O 94/06088 214 3 0 9 4 PC~r/SE93/00708 ~
Conveniently, the invention is implemented in portable "wallet-size" computers.
As appears from the drawing, the method is founded on a knowledge-based computer system or expert system 6 having a r~mi n~er function 1, a recording and storage function 2, 3, as well as a function 4 for inductive rule generation.
When the system is operating, the reminder function 1 is normally activated. The computer emits a signal when a pharmaceutical preparation is to be taken (or some other activity is to be performed), and advises on the type of preparation to be taken as well as the dosage. In the recording function 2 of the system, the patient confirms that the medicine has been taken, and then indicates his current state of health by respon~ing to guestions put to him by the computer. In addition, the patient separately records other relevant events, such as awakP.ni ng, intake of food, exercise and stress, when these occur, and also indicates his current state of health.
These data are stored in a database 3 together with the point of time at issue. Optionally, some information may be automatically retrieved by sensors.
The information, which constitutes a situation data-base 3, is used for determi ni ng relevant relations in time between various events and to generate examples distin-guishing the different symptoms that are to be controlled.
The examples consist of values for the attributes (affect-ing factors) that are relevant, as well as the associated symptom value (conclusion). The attributes used for each preparation are, among others, "latest dosage", "time from intake", and "rem~in;ng duration of action".
Collections of examples are automatically created every day for each group of symptoms. These collections are accumulated in a "rolling" database, preferably including the values from the last 20 days. The examples are then used in each group of symptoms for spotting, with the aid of prior-art inductive data analysis 4, the rela-2143~94 tionships that exist, and drafting rules for predictingthe symptoms.
Inductive data analysis and rule generation are described in, inter alia, the following publications:
Quinlan, JR (1979), Discovering Rules by Induction from Large Collections of Examples, Introductory ReA~ ings in Expert Systems (D. Michie), pp 33-46, London; Gordon and Breach 1979. Quinlan, JR (1983), Learning from Noisy Data, ProcPe~;ngs of the International ~Ach;n~ Learning Work-shop, University of Illinois, pp 58-64, 1986.
The prediction rules are generated in the form of decision trees and/or so-called conditional rules of the type:
IF X1<0.12 AND Z3="protein B" AND Z1>0.34 AND Z2=2 THEN
RIGIDITY = "excessive agility".
The rules are validated by being tested at 5 against borderline cases drawn up on long-term experience. Approv-ed rules are transferred to the knowledge base in an expert system 6 in known ~~nne~. The expert system may be a conventional rule-based system or be based on fuzzy logic. Then, the expert system is able to predict the state of health of the patient by part predictions of the various symptoms in a specific situation.
When in use, the expert system is automatically called at 8 at regular time intervals, preferably every fifth minute. When called, the system is consulted with respect to the current values from the situation database.
In consultation, time data are displaced forwards, pre-ferably by a time factor corresponding to the time elaps-ing from the intake of a preparation to the attainment of its biophase. This makes it possible for the system to signal before any undesirable effects appear (early warn-ing system). The consultation is performed in known manner via "backward chaining", i.e. starting from a desirable W O 94/06088 PC~r/SE93/00708 ~
21~3~9 4 -conclusion (state of health). Desirable conclusions can be predetermined for every group of symptoms.
The expert system operates in real time and can, in each specific situation, find in good time the prerequi-sites and conditions that have to be met to achieve thedesired state of health. If this state cannot be achieved in a specific situation (e.g. because the patient has forgotten to act on previous advice), the system looks for the prerequisites for att~;n;ng the "second-best" state of health. Induction of rules and updating of the knowledge base are performed automatically by the system, conve-niently once every twenty-fourth hour. Because the system learns to detect patterns by induction of real situations, the system can provide individualised medication advice without having access to explicit causal connections and pharmacological data, the prerequisite being that the attributes used directly or indirectly represent patterns that can be classified. According to the invention, the patient records the point of time when he takes the various preparations, the dosage as well as his current state of health. These data are used for generating, by inductive data analysis, prediction rules that are used for providing advice on the point of time and the dosage.
For each preparation, one starts from a patient-spe-cific longest nom;n~l duration of action. In the examples,the remaining duration of action as well as the dosage of the latest and the latest-but-one intake are determined.
Also other relevant factors, such as the intake of food, state of stress and related time, are also included in the examples.
The prediction rules generated by prior-art inductive data analysis are called at predetermined intervals, and a time delay is then introduced, which preferably corre-sponds to the time elapsing, in the case of the different preparations, from the intake to the att~i~ent of the biophase. The prediction rules are called by backward chain, primarily in order to satisfy the current situation 21~30~
;-to attain the desired state of health. If any of the con-ditions that can be influenced is not satisfied, e.g. the dosage of a preparation, the system will rer~- ?nA that this be done.
5 A mode of operation of the invention, intPn~P~ for controlled, individualised adaptive medication in the treatment of Parkinson's disease, will be described below.
In Parkinson's disease, the body cannot produce sufficient amounts of a neurotransmitter in the brain called dopa-mine, which results in limitations of movement, muscular cramp and tremor. This state can be counteracted by the supply of various preparations, such as L-dopa, which are converted to dopamine or the substance bromokriptin. In order to master undesirable side-effects, such as effects on the blood pressure, these preparations generally have to be combined with other medicines. Thus, medication fre-quently involves at least three different preparations, each having a specific dosage and a specific time inter-val between administrations. Owing to the interactions taking place, the time intervals and the doses have to be adapted to one another. Also external factors, such as the intake of food, exercise and state of stress, affect the action of the preparations. As a result, patients that have been ill for a long time, and thus have had plenty of time to find which medication suits them best, are seldom perfectly untroubled for a whole day. Freguently, there are two or more periods during the day in which they expe-rience considerable discomfort in the form of tremor, rigidity and "dullness of mind". Too low a dosage typi-cally results in tremor, rigidity and muscular cramp. Dis-comfort caused by overdosage is not less common, manifest-ing itself in the form of uncontrolled excessive agility, among other things. The reminder function indicates when the preparations, such as Pravidel, Sinemet, Inderal, Madopark, and Eldepryl, are to be taken, and further pro-vides r~commendations as to the intake of liquid, food and rest.
21~3~
The recording function includes compulsory input of the state of health expressed as degrees of the attributes "Rigidity", "Agility", "Tremor" and "Dullness of Mind".
Recordation is also performed when other important events take place, such as "awakening", "falling asleep", "eat-ing" and "drinking". In recordation, the time is indicated in minutes from the awakenin~.
When generating examples, the times elapsing from the intake of the various preparations and events to the pre-sent time are determined. Two times are preferably deter-mined for each preparation, namely the time that has elapsed from the latest-but-one intake and the time that has elapsed from the latest intake.
A no~;n~l duration of action from the intake is used for the various preparations. When the individual duration of action is known, this is indicated.
At the end of each day, a collection of examples with attribute values determined as above is created.
The recorded state of health is indicated as conclusion for each example.
A collection of examples is thus made for each of the indicated states of health, i.e. one collection of exam-ples with the conclusion related to "Rigidity", one col-lection related to "Tremor", and one collection related to "Dullness of Mind". Then, rules are induced from the col-lections of examples, and the rules are validated by com-paring their threshold values with indicated ~X;~um and um limits as to dosage and time.
If a rule falls outside these limits, the indicated limit values are used.
Thereafter, the rules are transferred to the know-ledge base in a deductive expert system.
The generation of examples, the induction and the transfer to the database are initiated at the end of each day and are perfectly automatic.
-- 21~309~
W O 94/06088 ^ PC~r/SE93/00708 When using the system, the reminder function is acti-vated when the patient starts the computer upon awaken; ng.
The r~ nA~r function calls the expert ~ tem at intervals of preferably about 5 min, and the expert system is thus consulted with respect to the data recorded. In consultation, an advance tim~ corresponding to the average time elapsing from the intake of a preparation to its com-menced action, is added to the real time. Preferably, the advance time is 30 min. Consequently, the system will be able to issue reminders in good time.
Claims (9)
1. A method for controlled, individualised medica-tion, c h a r a c t e r i s e d by recording, every time the patient takes his medicine, the type of medicine, the dose and the point of time in a database, recording information on the patient's state of health on recurrent occasions in the database, analysing the information recorded in the database by means of inductive data analysis in order to establish medication rules on the basis of detected relationships between the patient's intake of medicine and his state of health, comparing the established medication rules with pre-determined medication conditions for approval, using the approved rules for continuously deciding whether medication is to be performed and, if so, deciding the type of medicine and the dose, and repeating the analysis of the database for conti-nuously optimising the medication rules with the aid of new information recorded in the database and for adapting the rules to changes in the patient's state of health.
2. A method as set forth in claim 1, c h a r a c -t e r i s e d by the medication comprising the admini-stration of at least two different medicines.
3. A method as set forth in claim 1 or 2, c h a r -a c t e r i s e d by also recording information on the patient's intake of food and his activities in the data-base, and taking this information into consideration when establishing the medication rules.
4. A method as set forth in any one of the preceding claims, c h a r a c t e r i s e d by always recording the patient's state of health when recording his intake of medicine.
5. A method as set forth in any one of the preced-ing claims, c h a r a c t e r i s e d by calculating the relations in time between various external events recorded and the state of health recorded.
6. A method as set forth in any one of the preced-ing claims, c h a r a c t e r i s e d by allotting a duration of action to each medicine, and continuously calculating the remaining duration of action of the medicine taken.
7. A method as set forth in any one of the preced-ing claims, c h a r a c t e r i s e d by using the dose and the remaining duration of action as attributes in the inductive data analysis.
8. A method as set forth in any one of the preced-ing claims, c h a r a c t e r i s e d by being used in the treatment of Parkinson's disease.
9. A device for controlled, individualised medica-tion, c h a r a c t e r i s e d by means (2) for record-ing information on the intake of medicine and the pa-tient's state of health, a database (3) for storing this information, a program (4) for performing an inductive analysis of the information stored in the database and establishing medication rules on the basis of detected relationships between the intake of medicine and the patient's state of health, memory means (5) for storing predetermined medication conditions, means (5) for com-paring the medication rules established by means of the program for performing inductive analysis and the pre-determined medication conditions for approval of the medi-cation rules, an expert system (6) where the approved rules are used for deciding whether medication is to be performed and, if so, which type of medicine and what dose should be given, means (7) for activating the program for inductive analysis at given points of time, and means (8) for polling the expert system at given points of time.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9202460A SE500122C2 (en) | 1992-08-27 | 1992-08-27 | Method and apparatus for individually controlled, adaptive medication |
SE9202460-3 | 1992-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2143094A1 true CA2143094A1 (en) | 1994-03-17 |
Family
ID=20387020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002143094A Abandoned CA2143094A1 (en) | 1992-08-27 | 1993-08-27 | Method and apparatus for controlled individualized medication |
Country Status (6)
Country | Link |
---|---|
US (1) | US5672154A (en) |
EP (1) | EP0657051A1 (en) |
JP (1) | JPH08500513A (en) |
CA (1) | CA2143094A1 (en) |
SE (1) | SE500122C2 (en) |
WO (1) | WO1994006088A1 (en) |
Families Citing this family (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE512207C2 (en) * | 1993-11-26 | 2000-02-14 | Meditelligence Ab | Drug storage device |
USRE43433E1 (en) | 1993-12-29 | 2012-05-29 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US5660176A (en) | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US5935060A (en) | 1996-07-12 | 1999-08-10 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including list based processing |
US6206829B1 (en) * | 1996-07-12 | 2001-03-27 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
US5612869A (en) * | 1994-01-21 | 1997-03-18 | Innovative Enterprises International Corporation | Electronic health care compliance assistance |
DE19612668C1 (en) * | 1996-03-29 | 1997-08-21 | Martin Dr Med Busch | Radiation data optimisation method for radiation therapy |
DE19614255C1 (en) * | 1996-04-11 | 1997-09-18 | Falk Von Dr Med Zitzewitz | Device for registering mental values |
US5954640A (en) * | 1996-06-27 | 1999-09-21 | Szabo; Andrew J. | Nutritional optimization method |
US8734339B2 (en) | 1996-12-16 | 2014-05-27 | Ip Holdings, Inc. | Electronic skin patch for real time monitoring of cardiac activity and personal health management |
CN1252877A (en) * | 1997-03-13 | 2000-05-10 | 第一咨询公司 | Disease management system |
US5908383A (en) * | 1997-09-17 | 1999-06-01 | Brynjestad; Ulf | Knowledge-based expert interactive system for pain |
US6003020A (en) * | 1997-10-30 | 1999-12-14 | Sapient Health Network | Intelligent profiling system |
CA2277826A1 (en) | 1997-11-14 | 1999-05-27 | William M. Jenkins | A computerized device for improving motor control in an individual by sensory training |
US6234965B1 (en) | 1998-03-31 | 2001-05-22 | Scientific Learning Corporation | Methods and apparatus for improving biochemical based therapy in humans |
US6168562B1 (en) * | 1998-03-31 | 2001-01-02 | Scientific Learning Corporation | Method and apparatus for dynamically tailoring biochemical based therapy programs in human |
AU750822B2 (en) * | 1998-04-03 | 2002-08-01 | Triangle Pharmaceuticals, Inc. | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
US6282531B1 (en) | 1998-06-12 | 2001-08-28 | Cognimed, Llc | System for managing applied knowledge and workflow in multiple dimensions and contexts |
US7209787B2 (en) | 1998-08-05 | 2007-04-24 | Bioneuronics Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US7747325B2 (en) | 1998-08-05 | 2010-06-29 | Neurovista Corporation | Systems and methods for monitoring a patient's neurological disease state |
US9375573B2 (en) * | 1998-08-05 | 2016-06-28 | Cyberonics, Inc. | Systems and methods for monitoring a patient's neurological disease state |
US9113801B2 (en) | 1998-08-05 | 2015-08-25 | Cyberonics, Inc. | Methods and systems for continuous EEG monitoring |
US6165126A (en) * | 1998-08-14 | 2000-12-26 | Scientific Learning Corporation | Remediation of depression through computer-implemented interactive behavioral training |
US6231344B1 (en) | 1998-08-14 | 2001-05-15 | Scientific Learning Corporation | Prophylactic reduction and remediation of schizophrenic impairments through interactive behavioral training |
US6188648B1 (en) | 1998-11-03 | 2001-02-13 | Toni L. Olsen | Diabetic care overview wristwatch |
KR100627990B1 (en) * | 1998-11-30 | 2006-09-26 | 노보 노르디스크 에이/에스 | A method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions |
US6540672B1 (en) * | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US20090076857A1 (en) * | 1999-02-19 | 2009-03-19 | Cerner Innovation, Inc. | Systems and methods for managing patient pharmaceutical care |
US6277071B1 (en) | 1999-06-25 | 2001-08-21 | Delphi Health Systems, Inc. | Chronic disease monitor |
US6687190B2 (en) * | 1999-07-23 | 2004-02-03 | Robert Momich | Method and apparatus for clinical trials |
US6464136B2 (en) | 1999-12-28 | 2002-10-15 | Christopher S. Walsh | Record and verification method, apparatus and system |
US6497358B1 (en) | 1999-09-13 | 2002-12-24 | Christopher S. Walsh | Record and verification method and system for radiation therapy |
WO2001022330A1 (en) * | 1999-09-23 | 2001-03-29 | Infoscriber Corporation | Medical information system and method to obtain reasoning for therapeutic events |
US7269586B1 (en) * | 1999-12-22 | 2007-09-11 | Hitachi America, Ltd. | Patient rule induction method on large disk resident data sets and parallelization thereof |
US6317700B1 (en) | 1999-12-22 | 2001-11-13 | Curtis A. Bagne | Computational method and system to perform empirical induction |
AU2001234908A1 (en) * | 2000-02-11 | 2001-08-20 | Marcio Marc Abreu | System and method for communicating product recall information, product warningsor other product-related information to users of products |
UA73967C2 (en) * | 2000-02-14 | 2005-10-17 | First Opinion Corp | Structure-based automatic processing for diagnostics (variants) |
US10353856B2 (en) | 2011-03-17 | 2019-07-16 | Carefusion 303, Inc. | Scalable communication system |
US10062457B2 (en) | 2012-07-26 | 2018-08-28 | Carefusion 303, Inc. | Predictive notifications for adverse patient events |
AU6172301A (en) | 2000-05-18 | 2001-11-26 | Alaris Meidical Systems Inc | Distributed remote asset and medication management drug delivery system |
US7860583B2 (en) | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
US9427520B2 (en) | 2005-02-11 | 2016-08-30 | Carefusion 303, Inc. | Management of pending medication orders |
US9069887B2 (en) | 2000-05-18 | 2015-06-30 | Carefusion 303, Inc. | Patient-specific medication management system |
US11087873B2 (en) | 2000-05-18 | 2021-08-10 | Carefusion 303, Inc. | Context-aware healthcare notification system |
US9741001B2 (en) | 2000-05-18 | 2017-08-22 | Carefusion 303, Inc. | Predictive medication safety |
US7447643B1 (en) | 2000-09-21 | 2008-11-04 | Theradoc.Com, Inc. | Systems and methods for communicating between a decision-support system and one or more mobile information devices |
US8715177B2 (en) | 2000-10-06 | 2014-05-06 | Ip Holdings, Inc. | Intelligent drug delivery appliance |
US20060136142A1 (en) * | 2000-11-02 | 2006-06-22 | Kurt Berlin | Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA |
US7024398B2 (en) | 2000-11-02 | 2006-04-04 | Scientific Learning Corporation | Computer-implemented methods and apparatus for alleviating abnormal behaviors |
US20020077860A1 (en) * | 2000-12-18 | 2002-06-20 | Earnest Jocelyn Branham | Method and system for assisting in determining when to order supplemental medical information about a patient |
US20060235623A1 (en) * | 2001-01-19 | 2006-10-19 | Patrick Rambaud | Method of processing biological analysis data and expert system of biological analysis applying this method |
CA2440060A1 (en) * | 2001-02-09 | 2002-08-22 | Brian Christopher Tarbox | Systems and methods for improving investment performance |
US20030014222A1 (en) * | 2001-02-28 | 2003-01-16 | Klass David B. | Method and system for monitoring patient care |
US20020129342A1 (en) * | 2001-03-07 | 2002-09-12 | David Kil | Data mining apparatus and method with user interface based ground-truth tool and user algorithms |
US6879970B2 (en) * | 2001-04-02 | 2005-04-12 | Invivodata, Inc. | Apparatus and method for prediction and management of subject compliance in clinical research |
US7873589B2 (en) | 2001-04-02 | 2011-01-18 | Invivodata, Inc. | Operation and method for prediction and management of the validity of subject reported data |
US8065180B2 (en) | 2001-04-02 | 2011-11-22 | invivodata®, Inc. | System for clinical trial subject compliance |
US8533029B2 (en) | 2001-04-02 | 2013-09-10 | Invivodata, Inc. | Clinical monitoring device with time shifting capability |
US6655583B2 (en) * | 2001-04-13 | 2003-12-02 | Advanced Medical Interventions, Inc. | Medical billing method and system |
US6549796B2 (en) * | 2001-05-25 | 2003-04-15 | Lifescan, Inc. | Monitoring analyte concentration using minimally invasive devices |
SE0102694L (en) * | 2001-08-08 | 2003-02-09 | Rosengren Teknik Ab | Personal tools for managing medicine |
US20030037063A1 (en) * | 2001-08-10 | 2003-02-20 | Qlinx | Method and system for dynamic risk assessment, risk monitoring, and caseload management |
US20030101076A1 (en) * | 2001-10-02 | 2003-05-29 | Zaleski John R. | System for supporting clinical decision making through the modeling of acquired patient medical information |
FI20021031A (en) * | 2001-12-28 | 2003-06-29 | Pertti Laehteenmaeki | Nutritional Machine |
FI20012593A0 (en) * | 2001-12-28 | 2001-12-28 | Pertti Laehteenmaeki | A method and system for providing a nutrition information service |
EP1464026A2 (en) * | 2002-01-11 | 2004-10-06 | Hexalog SA | Systems and methods for medication monitoring |
US7225813B2 (en) * | 2002-08-23 | 2007-06-05 | Board Of Trustees Of The University Of Arkansas | Rib fracture score and protocol |
US8626522B2 (en) | 2002-09-20 | 2014-01-07 | Neurotech Research Pty. Ltd. | Condition analysis |
US11361853B2 (en) | 2002-10-29 | 2022-06-14 | Practice Velocity, LLC | Method and system for automated medical records processing with telemedicine |
US10714213B2 (en) | 2002-10-29 | 2020-07-14 | Practice Velocity, LLC | Method and system for automated medical records processing with patient tracking |
US7624027B1 (en) | 2002-10-29 | 2009-11-24 | Practice Velocity, LLC | Method and system for automated medical records processing |
US8606594B2 (en) | 2002-10-29 | 2013-12-10 | Practice Velocity, LLC | Method and system for automated medical records processing |
US9842188B2 (en) | 2002-10-29 | 2017-12-12 | Practice Velocity, LLC | Method and system for automated medical records processing with cloud computing |
CA2411203A1 (en) * | 2002-11-05 | 2004-05-05 | Alphaglobal It Inc. | Intelligent data management system and method |
US7890341B2 (en) * | 2002-12-09 | 2011-02-15 | Baxter International Inc. | System and a method for providing integrated access management for peritoneal dialysis and hemodialysis |
US20040111293A1 (en) * | 2002-12-09 | 2004-06-10 | Catherine Firanek | System and a method for tracking patients undergoing treatment and/or therapy for renal disease |
US7780595B2 (en) | 2003-05-15 | 2010-08-24 | Clinical Decision Support, Llc | Panel diagnostic method and system |
US20050027560A1 (en) * | 2003-07-28 | 2005-02-03 | Deborah Cook | Interactive multi-user medication and medical history management method |
US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
JP2007512588A (en) * | 2003-10-29 | 2007-05-17 | ノボ・ノルデイスク・エー/エス | Medical advice system |
US8029454B2 (en) | 2003-11-05 | 2011-10-04 | Baxter International Inc. | High convection home hemodialysis/hemofiltration and sorbent system |
WO2005053608A2 (en) * | 2003-11-26 | 2005-06-16 | D Silva Joe | Preparing for individualized dosage forms of medicaments |
AU2004298025B9 (en) | 2003-12-05 | 2010-12-09 | Carefusion 303, Inc. | System and method for network monitoring of multiple medical devices |
US7383238B1 (en) | 2004-02-24 | 2008-06-03 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Inductive monitoring system constructed from nominal system data and its use in real-time system monitoring |
US7762181B2 (en) * | 2004-10-01 | 2010-07-27 | Fonterra Co-Operative Group Limited | Customised nutritional food and beverage dispensing system |
JP2008515505A (en) * | 2004-10-07 | 2008-05-15 | ノボ・ノルデイスク・エー/エス | Methods and systems for disease self-management |
US9081879B2 (en) | 2004-10-22 | 2015-07-14 | Clinical Decision Support, Llc | Matrix interface for medical diagnostic and treatment advice system and method |
US20080171913A1 (en) * | 2004-11-15 | 2008-07-17 | Novo Nordisk A/S | Method and Apparatus for Monitoring Long Term and Short Term Effects of a Treatment |
US20060111943A1 (en) * | 2004-11-15 | 2006-05-25 | Wu Harry C | Method and system to edit and analyze longitudinal personal health data using a web-based application |
US8296162B1 (en) | 2005-02-01 | 2012-10-23 | Webmd Llc. | Systems, devices, and methods for providing healthcare information |
US8532938B2 (en) | 2005-11-17 | 2013-09-10 | The Invention Science Fund I, Llc | Testing-dependent administration of a nutraceutical |
US8468029B2 (en) * | 2005-11-17 | 2013-06-18 | The Invention Science Fund I, Llc | Subscriptions for assistance related to health |
US10042980B2 (en) | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
US20070112592A1 (en) * | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Payments in providing assistance related to health |
US8000981B2 (en) * | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
US7927787B2 (en) | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
US20080103746A1 (en) | 2005-11-30 | 2008-05-01 | Searete Llc, A Limited Liability Corporation | Systems and methods for pathogen detection and response |
US8340944B2 (en) | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US8297028B2 (en) * | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US7974856B2 (en) * | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
US8868172B2 (en) | 2005-12-28 | 2014-10-21 | Cyberonics, Inc. | Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders |
US20070260480A1 (en) * | 2006-05-04 | 2007-11-08 | Johan Cederlund | Managing health related variables in a remote data collection system |
US20070299695A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20080086338A1 (en) * | 2006-06-23 | 2008-04-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20080027348A1 (en) * | 2006-06-23 | 2008-01-31 | Neuro Vista Corporation | Minimally Invasive Monitoring Systems for Monitoring a Patient's Propensity for a Neurological Event |
US20080086339A1 (en) * | 2006-06-23 | 2008-04-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20080091466A1 (en) | 2006-10-16 | 2008-04-17 | Hospira, Inc. | System and method for comparing and utilizing activity information and configuration information from multiple device management systems |
US8295934B2 (en) | 2006-11-14 | 2012-10-23 | Neurovista Corporation | Systems and methods of reducing artifact in neurological stimulation systems |
WO2008092119A2 (en) * | 2007-01-25 | 2008-07-31 | Neurovista Corporation | Systems and methods for identifying a contra-ictal condition in a subject |
US20080183097A1 (en) * | 2007-01-25 | 2008-07-31 | Leyde Kent W | Methods and Systems for Measuring a Subject's Susceptibility to a Seizure |
US8380530B2 (en) | 2007-02-02 | 2013-02-19 | Webmd Llc. | Personalized health records with associative relationships |
US8036736B2 (en) | 2007-03-21 | 2011-10-11 | Neuro Vista Corporation | Implantable systems and methods for identifying a contra-ictal condition in a subject |
US9788744B2 (en) * | 2007-07-27 | 2017-10-17 | Cyberonics, Inc. | Systems for monitoring brain activity and patient advisory device |
DE102007048094B4 (en) * | 2007-10-05 | 2011-07-28 | Mayer-Paris, Sabine, 70563 | Method and device for detecting effects on an organism |
US8517990B2 (en) | 2007-12-18 | 2013-08-27 | Hospira, Inc. | User interface improvements for medical devices |
US20090171168A1 (en) | 2007-12-28 | 2009-07-02 | Leyde Kent W | Systems and Method for Recording Clinical Manifestations of a Seizure |
US9259591B2 (en) | 2007-12-28 | 2016-02-16 | Cyberonics, Inc. | Housing for an implantable medical device |
US8380531B2 (en) | 2008-07-25 | 2013-02-19 | Invivodata, Inc. | Clinical trial endpoint development process |
EP2347008B1 (en) * | 2008-10-20 | 2022-06-29 | Epitome Pharmaceuticals Limited | Methods and systems for improved pharmaceutical intervention in coagulation control |
US8849390B2 (en) | 2008-12-29 | 2014-09-30 | Cyberonics, Inc. | Processing for multi-channel signals |
US8588933B2 (en) | 2009-01-09 | 2013-11-19 | Cyberonics, Inc. | Medical lead termination sleeve for implantable medical devices |
US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
US8786624B2 (en) | 2009-06-02 | 2014-07-22 | Cyberonics, Inc. | Processing for multi-channel signals |
IT1396716B1 (en) * | 2009-06-17 | 2012-12-14 | Topani | ADAPTIVE MEDICATION DEVICE WITH AUTOMATIC WARNINGS AND ALARMS AND METHOD FOR THE SCHEDULED RECRUITMENT OF A DRUG |
US20110137680A1 (en) * | 2009-12-01 | 2011-06-09 | Patientsafe Solutions, Inc. | Hospital administration system and method |
US20110141116A1 (en) * | 2009-12-16 | 2011-06-16 | Baxter International Inc. | Methods and apparatus for displaying flow rate graphs and alarms on a dialysis system |
US8771251B2 (en) * | 2009-12-17 | 2014-07-08 | Hospira, Inc. | Systems and methods for managing and delivering patient therapy through electronic drug delivery systems |
US9643019B2 (en) | 2010-02-12 | 2017-05-09 | Cyberonics, Inc. | Neurological monitoring and alerts |
AU2012299169B2 (en) | 2011-08-19 | 2017-08-24 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US9594875B2 (en) | 2011-10-21 | 2017-03-14 | Hospira, Inc. | Medical device update system |
US10276054B2 (en) | 2011-11-29 | 2019-04-30 | Eresearchtechnology, Inc. | Methods and systems for data analysis |
US10022498B2 (en) | 2011-12-16 | 2018-07-17 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
US9995611B2 (en) | 2012-03-30 | 2018-06-12 | Icu Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
ES2743160T3 (en) | 2012-07-31 | 2020-02-18 | Icu Medical Inc | Patient care system for critical medications |
US11182728B2 (en) | 2013-01-30 | 2021-11-23 | Carefusion 303, Inc. | Medication workflow management |
US10430554B2 (en) | 2013-05-23 | 2019-10-01 | Carefusion 303, Inc. | Medication preparation queue |
EP2964079B1 (en) | 2013-03-06 | 2022-02-16 | ICU Medical, Inc. | Medical device communication method |
WO2014159280A1 (en) | 2013-03-13 | 2014-10-02 | Carefusion 303, Inc. | Patient-specific medication management system |
EP2973370A4 (en) | 2013-03-13 | 2016-08-17 | Carefusion 303 Inc | Predictive medication safety |
WO2014190264A1 (en) | 2013-05-24 | 2014-11-27 | Hospira, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
AU2014274146B2 (en) | 2013-05-29 | 2019-01-24 | Icu Medical, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
CA2913918C (en) | 2013-05-29 | 2022-02-15 | Hospira, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
US20150031004A1 (en) | 2013-07-24 | 2015-01-29 | Lumos Labs, Inc. | Physically intuitive, real-time, multiple object tracking, planning and divided attention task for enhancing cognition |
US20150066531A1 (en) | 2013-08-30 | 2015-03-05 | James D. Jacobson | System and method of monitoring and managing a remote infusion regimen |
US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
JP2016537175A (en) | 2013-11-19 | 2016-12-01 | ホスピーラ インコーポレイテッド | Infusion pump automation system and method |
EP3110474B1 (en) | 2014-02-28 | 2019-12-18 | ICU Medical, Inc. | Infusion system and method which utilizes dual wavelength optical air-in-line detection |
CA2945647C (en) | 2014-04-30 | 2023-08-08 | Hospira, Inc. | Patient care system with conditional alarm forwarding |
AU2015266706B2 (en) | 2014-05-29 | 2020-01-30 | Icu Medical, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
EP3161730A4 (en) | 2014-06-30 | 2018-02-28 | Evolving Machine Intelligence Pty Ltd. | A system and method for modelling system behaviour |
US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
EP3215990A4 (en) | 2014-11-03 | 2018-04-11 | Myaveta LLC | Systems and methods for formulating customized beverages |
US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
EP3304370B1 (en) | 2015-05-26 | 2020-12-30 | ICU Medical, Inc. | Infusion pump system and method with multiple drug library editor source capability |
JP6423810B2 (en) * | 2016-02-26 | 2018-11-14 | セコム株式会社 | Medication support system |
AU2017264784B2 (en) | 2016-05-13 | 2022-04-21 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
EP3468635A4 (en) | 2016-06-10 | 2019-11-20 | ICU Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
AU2017295722B2 (en) | 2016-07-14 | 2022-08-11 | Icu Medical, Inc. | Multi-communication path selection and security system for a medical device |
US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
US11483403B2 (en) | 2018-07-17 | 2022-10-25 | Icu Medical, Inc. | Maintaining clinical messaging during network instability |
WO2020018389A1 (en) | 2018-07-17 | 2020-01-23 | Icu Medical, Inc. | Systems and methods for facilitating clinical messaging in a network environment |
US10861592B2 (en) | 2018-07-17 | 2020-12-08 | Icu Medical, Inc. | Reducing infusion pump network congestion by staggering updates |
AU2019306490A1 (en) | 2018-07-17 | 2021-02-04 | Icu Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
CA3107315C (en) | 2018-07-26 | 2023-01-03 | Icu Medical, Inc. | Drug library management system |
US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
WO2022020184A1 (en) | 2020-07-21 | 2022-01-27 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
CA3142131A1 (en) | 2020-12-15 | 2022-06-15 | Bagne-Miller Enterprises, Inc. | Complex adaptive systems metrology by computation methods and systems |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2544525A1 (en) * | 1983-04-12 | 1984-10-19 | Simatec Sarl | PORTABLE APPARATUS FOR SEIZING AND PROCESSING INFORMATION RELATING TO THE HEALTH OF A PERSON |
EP0290683A3 (en) * | 1987-05-01 | 1988-12-14 | Diva Medical Systems B.V. | Diabetes management system and apparatus |
US4839822A (en) * | 1987-08-13 | 1989-06-13 | 501 Synthes (U.S.A.) | Computer system and method for suggesting treatments for physical trauma |
GB2218831A (en) * | 1988-05-17 | 1989-11-22 | Mark John Newland | Personal medical apparatus |
US5214745A (en) * | 1988-08-25 | 1993-05-25 | Sutherland John G | Artificial neural device utilizing phase orientation in the complex number domain to encode and decode stimulus response patterns |
US5126957A (en) * | 1989-09-29 | 1992-06-30 | Health Tech Services Corp. | Interactive medication delivery system |
JP2734207B2 (en) * | 1991-01-17 | 1998-03-30 | 株式会社日立製作所 | System voltage control method and device |
US5299121A (en) * | 1992-06-04 | 1994-03-29 | Medscreen, Inc. | Non-prescription drug medication screening system |
US5464103A (en) * | 1993-08-09 | 1995-11-07 | Side-Kik Corporation | Display rack |
-
1992
- 1992-08-27 SE SE9202460A patent/SE500122C2/en unknown
-
1993
- 1993-08-27 JP JP6507120A patent/JPH08500513A/en active Pending
- 1993-08-27 CA CA002143094A patent/CA2143094A1/en not_active Abandoned
- 1993-08-27 EP EP93919776A patent/EP0657051A1/en not_active Ceased
- 1993-08-27 WO PCT/SE1993/000708 patent/WO1994006088A1/en not_active Application Discontinuation
- 1993-08-27 US US08/387,943 patent/US5672154A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08500513A (en) | 1996-01-23 |
EP0657051A1 (en) | 1995-06-14 |
SE500122C2 (en) | 1994-04-18 |
WO1994006088A1 (en) | 1994-03-17 |
SE9202460D0 (en) | 1992-08-27 |
US5672154A (en) | 1997-09-30 |
SE9202460L (en) | 1994-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2143094A1 (en) | Method and apparatus for controlled individualized medication | |
El Fathi et al. | The artificial pancreas and meal control: An overview of postprandial glucose regulation in type 1 diabetes | |
Harvey et al. | Quest for the artificial pancreas: combining technology with treatment | |
Bremer et al. | Is blood glucose predictable from previous values? A solicitation for data. | |
Goldstein et al. | Quantitative electroencephalographic analysis of naturally occurring (schizophrenic) and drug‐induced psychotic states in human males | |
CN109887568B (en) | Health management system based on doctor's advice | |
AU754171B2 (en) | Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients | |
US6827690B2 (en) | System and method for providing diagnosis and monitoring of myocardial ischemia for use in automated patient care | |
US7837629B2 (en) | System and method for generating baseline data for automated management of edema | |
US7988630B1 (en) | Method and system for implantable glucose monitoring and control of a glycemic state of a subject | |
US20090177147A1 (en) | Insulin pump with insulin therapy coaching | |
CN108697336A (en) | Device for administering and method | |
Cinar | Multivariable adaptive artificial pancreas system in type 1 diabetes | |
Cinar et al. | Advances in Artificial Pancreas Systems: Adaptive and Multivariable Predictive Control | |
CN113383395A (en) | Decision support software system for sleep disorder recognition | |
US20210068669A1 (en) | Systems And Methods For Prediction Of Glycemia And Decisions Support | |
CN114732402B (en) | Diabetes digital health management system based on big data | |
US20220093229A1 (en) | Apparatus and method for calculating an optimum medication dose | |
Maçar | Time psychophysics and related models | |
Ekram et al. | A feedback glucose control strategy for type II diabetes mellitus based on fuzzy logic | |
Kapil et al. | Artificial pancreas system for type 1 diabetes—challenges and advancements | |
Reichler et al. | Overview of biomedical issues in autism | |
Birky et al. | A comparison of residents discharged from a token economy and two traditional psychiatric programs | |
Cameron et al. | Does continuous glucose monitoring have clinical utility in contemporary management of diabetes? | |
Heald et al. | The FreeStyle Libre flash glucose monitoring system: How it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 19990827 |